Kayne Anderson Rudnick Investment Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-30
Closed -$4K 606
2022
Q1
$4K Buy
+30
New +$4K ﹤0.01% 572